Cytokine Therapy for Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|6|6|681-699

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.6, Iss.6, 2000-04, pp. : 681-699

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Controlled-release Particulate Cytokine Adjuvants for Cancer Therapy

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 4, 2007-12 ,pp. : 266-270

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokine Network: New Targeted Therapy for Pancreatic Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 17, 2012-06 ,pp. : 2416-2419

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokine-Directed Therapy in Asthma

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-09 ,pp. : 263-269

Bentham Science Publishers

Access to resources Recommend Favorite

Adding cytokine-induced killer (CIK) cell therapy to the FOLFOX4 regimen is beneficial for treating advanced gastric cancer

By  

Inpharma, Vol. 1, Iss. 1548, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

IL-17F, a target for anti-cytokine therapy

By Maitra Amarnath   Gaffen Sarah L  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 4, 2007-04 ,pp. : 453-458

Informa Healthcare

Access to resources Recommend Favorite